radioligand therapy

You have access
Tumor sink effect in ⁶⁸Ga-PSMA-11 PET: Myth or Reality?
Andrei Gafita, Hui Wang, Andrew Robertson, Wesley Robert Armstrong, Raphael Zaum, Manuel Weber, Farid Yagubbayli, Clemens Kratochwil, Tristan R Grogan, Kathleen Nguyen, Fernando Navarro, Rouzbeh Esfandiari, Isabel Rauscher, Bjoern Menze, David Elashoff, Ebrahim S. Delpassand, Ken Herrmann, Johannes Czernin, Michael S Hofman, Jeremie Calais, Wolfgang Peter Fendler and Matthias Eiber

Journal of Nuclear Medicine May 28, 2021, jnumed.121.261906; DOI: https://doi.org/10.2967/jnumed.121.261906
You have access
First Clinical Results for PSMA-Targeted α-Therapy Using ²²⁵Ac-PSMA-I&T in Advanced-mCRPC Patients
Mathias Johannes Zacherl, Franz Josef Gildehaus, Lena Mittlmeier, Guido Böning, Astrid Gosewisch, Vera Wenter, Marcus Unterrainer, Nina Schmidt-Hegemann, Claus Belka, Alexander Kretschmer, Jozefina Casuscelli, Christian G. Stief, Marcus Unterrainer, Peter Bartenstein, Andrei Todica and Harun Ilhan

Journal of Nuclear Medicine May 10, 2021, 62 (5) 669-674; DOI: https://doi.org/10.2967/jnumed.120.251017
You have access
Assessing Response to [¹⁷⁷Lu]PSMA Radioligand Therapy using modified PSMA PET Progression Criteria
Kerstin Michalski, Claudius Klein, Tonio Brueggemann, Philipp T Meyer, Cordula Annette Jilg and Juri Ruf

Journal of Nuclear Medicine March 31, 2021, jnumed.120.260836; DOI: https://doi.org/10.2967/jnumed.120.260836
You have access
¹⁷⁷Lu-Labeled Albumin-Binder–Conjugated PSMA-Targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-Kidney Absorbed Dose Ratio
Hsiou-Ting Kuo, Kuo-Shyan Lin, Zhengxing Zhang, Carlos F. Uribe, Helen Merkens, Chengcheng Zhang and François Bénard

Journal of Nuclear Medicine April 1, 2021, 62 (4) 521-527; DOI: https://doi.org/10.2967/jnumed.120.250738
You have access
Landscape analysis of phase 2/3 clinical trials of targeted radionuclide therapy
Erik Mittra, Amanda Abbott and Lisa Bodei

Journal of Nuclear Medicine February 12, 2021, jnumed.120.258103; DOI: https://doi.org/10.2967/jnumed.120.258103
You have access
¹⁷⁷Lu-EB-PSMA Radioligand Therapy with Escalating Doses in Patients with Metastatic Castration-Resistant Prostate Cancer
Jie Zang, Qingxing Liu, Huimin Sui, Rongxi Wang, Orit Jacobson, Xinrong Fan, Zhaohui Zhu and Xiaoyuan Chen

Journal of Nuclear Medicine December 1, 2020, 61 (12) 1772-1778; DOI: https://doi.org/10.2967/jnumed.120.242263
You have access
Neuroendocrine Differentiation and Response to PSMA-Targeted Radioligand Therapy in Advanced Metastatic Castration-Resistant Prostate Cancer: A Single-Center Retrospective Study
Thorsten Derlin, Rudolf A. Werner, Marcel Lafos, Christoph Henkenberens, Christoph A.J. von Klot, Jan M. Sommerlath Sohns, Tobias L. Ross and Frank M. Bengel

Journal of Nuclear Medicine November 1, 2020, 61 (11) 1602-1606; DOI: https://doi.org/10.2967/jnumed.120.241588
You have access
Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of ¹⁷⁷Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer
John Violet, Shahneen Sandhu, Amir Iravani, Justin Ferdinandus, Sue-Ping Thang, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, David Pattison, Alexis Beaulieu, Jennifer Mooi, Ben Tran, Christina Guo, Victor Kalff, Declan G Murphy, Price Jackson, Peter Eu, Mark Scalzo, Scott Williams, Rodney J. Hicks and Michael S. Hofman

Journal of Nuclear Medicine June 1, 2020, 61 (6) 857-865; DOI: https://doi.org/10.2967/jnumed.119.236414
You have access
Response Prediction of ¹⁷⁷Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate Dehydrogenase
Hendrik Rathke, Tim Holland-Letz, Walter Mier, Paul Flechsig, Eleni Mavriopoulou, Manuel Röhrich, Klaus Kopka, Markus Hohenfellner, Frederik Lars Giesel, Uwe Haberkorn and Clemens Kratochwil

Journal of Nuclear Medicine May 1, 2020, 61 (5) 689-695; DOI: https://doi.org/10.2967/jnumed.119.231431
You have access
Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving ²²⁵Ac-PSMA-617 Radioligand Therapy
Mike Sathekge, Frank Bruchertseifer, Mariza Vorster, Ismaheel O. Lawal, Otto Knoesen, Johncy Mahapane, Cindy Davis, Florette Reyneke, Alex Maes, Clemens Kratochwil, Thabo Lengana, Frederik L. Giesel, Christophe Van de Wiele and Alfred Morgenstern

Journal of Nuclear Medicine January 1, 2020, 61 (1) 62-69; DOI: https://doi.org/10.2967/jnumed.119.229229

Main menu

User menu

Search

radioligand therapy

Pages